Legal & General Group PLC Roivant Sciences Ltd. Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Legal & General Group PLC holds 602,858 shares of ROIV stock, worth $6.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
602,858
Previous 641,442
6.02%
Holding current value
$6.26 Million
Previous $7.4 Million
3.66%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ROIV
# of Institutions
331Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$683 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$644 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$496 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$458 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$367 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.31B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...